Age, years

Medin

59

Range

17 - 81

Sex

Men

26

57

Women

20

43

Underlying disease

Acute myeloid Leukemia

17

36

Acute lymphoblastic leukemia

3

7

Malignant lymphoma

23

50

Multiple myeloma

3

7

Stem cell transplantation

Allogeneitc

2 (AML, ALL)^a

Autologous

3 (MM)^b

Duration of prophylaxis, days

Median

9.5

Range

2 - 37

Duration of neutropenia (<1000/μl), days

Median

10

Range

1 - 88

Duration of severe neutropenia (<100/μl), days

Median

4

Range

0 - 36